Thrombotic microangiopathy in a very young infant with mitral valvuloplasty

Yuka Matsunaga1, Masataka Ishimura1, Hazumu Nagata1

  • 1Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Japan.

Abstract

Insights

Post-operative thrombotic microangiopathy (TMA) in an infant with congenital heart disease resolved after mitral valve repair. This case highlights TMA

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Hematology

Background:

  • Thrombotic microangiopathies (TMA) are vascular disorders characterized by platelet aggregation, thrombocytopenia, and red cell fragmentation.
  • Post-operative TMA typically affects adults after cardiovascular surgery, with unclear pathophysiology distinct from TTP.
  • Congenital heart disease surgery presents unique challenges for TMA development in infants.

Observation:

  • A one-month-old infant developed TMA following double outlet right ventricle surgery.
  • ADAMTS13 activity was normal, but VWF multimer analysis showed absent high-molecular-weight multimers.
  • Severe mitral regurgitation was noted, suggesting a link to valvulopathy.

Findings:

  • TMA in this infant was associated with valvulopathy-induced turbulent shear flow, mechanical hemolysis, and endothelial damage.
  • Consumption of large VWF multimers likely contributed to vascular shear stress, similar to Heyde syndrome.
  • Mitral valve repair led to prompt resolution of TMA, confirming the association.

Implications:

  • This is the youngest reported case of post-operative TMA.
  • It underscores the critical coagulopathy risks following initial surgical interventions for congenital heart disease.
  • Early recognition and intervention for TMA in infants undergoing cardiac surgery are crucial.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
761
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
632
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
594
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
328
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
370
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
294